Roche’s virtual event following ASH 2023
Roche has hosted a virtual event on Tuesday, 12 December 2023
| Agenda | |
|---|---|
| Welcome | Bruno Eschli, Head of Investor Relations |
| Roche hematology strategy | Peter Ahnesorg, Franchise Head Hematology |
| Review of key data presented at ASH | Charles Fuchs, Senior Vice President - Global Head of Oncology and Hematology Product Development |
| Q&A |
Webinar Replay
Investors